###begin article-title 0
###xml 59 64 <span type="species:ncbi:10090">Mouse</span>
Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: ST JR. Performed the experiments: ST RG AFH EMW. Analyzed the data: ST RG EMW BC JR. Contributed reagents/materials/analysis tools: BC. Wrote the paper: BC JR.
###end p 1
###begin title 2
Objectives
###end title 2
###begin p 3
###xml 240 242 240 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
Ample clinical and experimental evidence indicated that patients with Alzheimer's disease display a high incidence of cardiovascular events. This study was designed to examine myocardial histology, cardiomyocyte shortening, intracellular Ca2+ homeostasis and regulatory proteins, electrocardiogram, adrenergic response, endoplasmic reticulum (ER) stress and protein carbonyl formation in C57 wild-type (WT) mice and an APPswe/PS1dE9 transgenic (APP/PS1) model for Alzheimer's disease.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 206 208 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Cardiomyocyte mechanical properties were evaluated including peak shortening (PS), time-to-PS (TPS), time-to-relengthening (TR), maximal velocity of shortening and relengthening (+/-dL/dt), intracellular Ca2+ transient rise and decay.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 213 214 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</sub>
###xml 239 241 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 306 308 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 336 338 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 518 519 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 604 606 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 755 756 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 759 761 754 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
Little histological changes were observed in APP/PS1 myocardium. Cardiomyocytes from APP/PS1 but not APP or PS1 single mutation mice exhibited depressed PS, reduced+/-dL/dt, normal TPS and TR compared with WT mice. Rise in intracellular Ca2+ was lower accompanied by unchanged resting/peak intracellular Ca2+ levels and intracellular Ca2+ decay in APP/PS1 mice. Cardiomyocytes from APP/PS1 mice exhibited a steeper decline in PS at high frequencies. The responsiveness to adrenergic agonists was dampened although beta1-adrenergic receptor expression was unchanged in APP/PS1 hearts. Expression of the Ca2+ regulatory protein phospholamban and protein carbonyl formation were downregulated and elevated, respectively, associated with unchanged SERCA2a, Na+-Ca2+ exchanger and ER stress markers in APP/PS1 hearts. Our further study revealed that antioxidant N-acetylcysteine attenuated the contractile dysfunction in APP/PS1 mice.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Our results depicted overt cardiomyocyte mechanical dysfunction in the APP/PS1 Alzheimer's disease model, possibly due to oxidative stress.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 582 585 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Selkoe1">[1]</xref>
###xml 965 968 956 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Bleumink1">[2]</xref>
###xml 969 973 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Rosendorff1">[10]</xref>
###xml 1136 1140 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Hebert1">[11]</xref>
###xml 1438 1442 1429 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Nakajima1">[12]</xref>
###xml 1572 1576 1563 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Takeda1">[13]</xref>
###xml 1693 1697 1684 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Li1">[14]</xref>
###xml 1344 1348 <span type="species:ncbi:10090">mice</span>
###xml 1684 1692 <span type="species:ncbi:9606">patients</span>
Alzheimer's disease (AD) is a devastating neurodegenerative disease leading to memory loss and cognitive impairment. Accumulation of amyloid beta-peptide (Abeta) and neurofibrillary tangles are considered hallmarks for neuropathological changes in AD. At this time, neither the precise pathogenesis nor radical cure is available for AD. Although majority of AD cases are idiopathic, an autosomal dominant disorder triggered by mutation in the beta-amyloid precursor protein (APP), presenilin 1 (PS1) or presenilin 2 (PS2) has been identified to be responsible for familial AD (FAD) [1]. Interestingly, AD is associated with a high prevalence of heart dysfunction in the elderly . Recent data has indicated a close tie between heart dysfunction and AD. A number of studies have revealed that the onset and progression of AD are closely associated with hypertension, atherosclerosis, diabetes mellitus, hypoxia, myocardial infarction and the presence of ApoE4 allele [2]-[10]. However, limited information is available with regards to the cardiovascular function in AD. Given that the AD genes PS1 and PS2 are also expressed in the heart [11], it may be speculated that mutations in these genes in familial AD affect cardiac function. Presenilins have been suggested to play a key role in the regulation of cardiovascular function. PS1-deficient mice exhibit ventricular septal defect and double outlet right ventricle in the mutant hearts [12]. PS2 also play an important role in cardiac excitation-contraction coupling by interacting with ryanodine receptor type 2 (RyR2) [13]. PS1 and PS2 mutations are associated with a higher risk of dilated cardiomyopathy and heart failure in AD patients [14].
###end p 11
###begin p 12
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Jankowsky1">[15]</xref>
###xml 505 509 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Taniuchi1">[16]</xref>
###xml 672 676 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-GarciaAlloza1">[17]</xref>
###xml 1031 1033 1019 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1162 1166 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Bers1">[18]</xref>
###xml 1168 1172 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Ren1">[19]</xref>
###xml 1194 1196 1182 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1256 1258 1244 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1301 1302 1289 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1305 1307 1293 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
###xml 402 417 <span type="species:ncbi:10090">transgenic mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 863 868 <span type="species:ncbi:10090">mouse</span>
###xml 919 924 <span type="species:ncbi:10090">mouse</span>
###xml 1524 1528 <span type="species:ncbi:10090">mice</span>
The recent development of transgenic mouse models of AD has provided an important avenue for AD research. Double transgenic mice overexpressing FAD-linked amyloid precursor protein with Swedish mutation and PS-1 with deletion of exon 9 (APPswe/PS1dE9) demonstrated early Abeta deposition as early as 4-6 months of age that correspond to a form of early onset AD [15]. At 9 months of age, APPswe/PS1dE9 transgenic mice display high levels of amyloid beta-peptide and numerous amyloid beta-peptide deposits [16]. Furthermore, the APPswe/PS1dE9 mice exhibit a consistent beta-amyloid accumulation early on and age-associated cognitive decline, consolidating the model for AD [17]. Although many studies have used this transgenic line to investigate aspects of neurodegenerative lesions in AD, no information is available with regards to the cardiac function of this mouse model of AD. Therefore, we took advantage of this mouse model of AD to examine cardiomyocyte mechanical function and underlying mechanisms. Since intracellular Ca2+ homeostasis and endoplasmic reticulum (ER) stress are known to be closely associated with cardiomyocyte contractile dysfunction [18], [19], key intracellular Ca2+ regulatory proteins such as sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), phospholamban (PLB) and Na+-Ca2+ exchanger (NCX) as well as crucial protein markers of ER stress including inositol requiring enzyme-1 (IRE-1), calregulin and Bip (GRP78) were also monitored in myocardium of APP/PS1 transgenic and wild-type C57BL/6 mice.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Experimental animals
###end title 14
###begin p 15
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Jankowsky1">[15]</xref>
###xml 1287 1325 1287 1325 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAC TGA CCA CTC GAC CAG GTT CTG -3&#8242;</named-content>
###xml 1329 1370 1329 1370 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> 5&#8242;- CTT GTA AGT TGG ATT CTC ATA TCC G-3&#8242;</named-content>
###xml 1382 1414 1382 1414 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAT AGA GAA CGG CAG GAG CA-3&#8242;</named-content>
###xml 1419 1451 1419 1451 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCC ATG AGG GCA CTA ATC AT-3&#8242;</named-content>
###xml 289 304 <span type="species:ncbi:10090">transgenic mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 705 710 <span type="species:ncbi:9606">human</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
All animal procedures were conducted in accordance with humane animal care standards outlined in the NIH Guide for the Care and Use of Experimental and were approved the University of Wyoming Animal Care and Use Committee. In brief, 10-month-old male C57BL/6 (WT), APPswe/PS1dE9 (APP/PS1) transgenic mice and mice with transgenic expression of only APPswe (APP) or PS1dE9 (PS1) (Jackson Laboratory, Bar Harbor, Maine, USA) were maintained on a 12:12-h light-dark cycle, with free access to food and water. Production and characterization of the APP/PS1 mouse line were described in detail previously [15]. In brief, APPswe/PS1dE9 mice were developed by co-injection of the two transgene constructs [mouse/human (Mo/Hu) chimeric APP695 harboring the Swedish (K594M/N595L) mutation and exon-9-deleted PS1] into pronuclei with a single genomic insertion site resulting in the two transgenes being transmitted as a single mendelian locus. To identify the transgenic founder mice, genomic DNA was isolated from 1-cm tail clips from 10-month-old mice and genotyped by polymerase chain reaction (PCR) technique using the PCR conditions suggested by Jackson Laboratory. All primers were synthesized by Integrated DNA Technologies Inc. (Coralville, IA, USA) with the following sequences. APPswe: 5'-GAC TGA CCA CTC GAC CAG GTT CTG -3' and 5'- CTT GTA AGT TGG ATT CTC ATA TCC G-3'; PSEN1dE9: 5'-AAT AGA GAA CGG CAG GAG CA-3' and 5'-GCC ATG AGG GCA CTA ATC AT-3'). Levels of fasting blood glucose and systolic blood pressure were measured using a glucose monitor (Accu-ChekII, model 792, Boehringer-Mannheim Diagnostics, Indianapolis, IN, USA) and a CODA non-invasive blood pressure system (Kent Scientific Co., Torrington, CT, USA), respectively. At the time of sacrifice, left tibial length was measured with a micrometer.
###end p 15
###begin title 16
Histological examination
###end title 16
###begin p 17
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Doser1">[20]</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Following anesthesia, hearts WT and APP/PSEN mice were excised and immediately placed in 10% neutral-buffered formalin at room temperature for 24 hrs after a brief rinse with PBS. Thereafter, the tissues were dehydrated through serial alcohols and cleared in xylenes. The specimen were then embedded in paraffin, cut in 5 microm sections and stained with hematoxylin and eosin (H&E) or Masson's trichrome (to detect fibrosis) for histological observation [20].
###end p 17
###begin title 18
Morris water maze test
###end title 18
###begin p 19
###xml 1115 1119 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Galvan1">[21]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
Mice aged 8-10 months from WT and APP/PS1 groups were subjected to behavioral testing. The Morris water maze tests were conducted in a 120-cm (diameter) tank filled with opaque water. The water was kept at 25degreesC and surrounded by dark walls containing geometric designs that served as distal visual cues. In the first phase of the training, mice were required to find a platform (15x15 cm) marked with a colored pole, placed in different quadrants of the pool. Each animal underwent four trials per day for 4 days, with a maximum of 60 s to find the submerged platform. If the mice failed to find the platform within 60 s, they were physically guided to it and allowed to remain on the platform for 20 s. After visible platform training, two consecutive days of hidden platform training was conducted in which the platform is submerged in the opaque water 1 cm deep, with 4 trials per day. A probe trial was performed at the end of training, in which the platform was removed. Performance in all tasks (latency to platform, time spent in target quadrant) was recorded by a computer-based video tracking system [21].
###end p 19
###begin title 20
ECG measurement
###end title 20
###begin p 21
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized with an intraperitoneal injection of ketamine HCl/xylazine HCl solution (1 ml/kg) and were placed in a supine position on a warm pad (37degreesC) for acclimatization. Afterwards, three surface probes were inserted subcutaneously and the ECG signal was obtained for 1 minute using a PowerLab (ML866) and Animal Bio Amp (ML136; AD Instruments, Colorado Springs, CO, USA). The signal was analyzed with Chart 5.0 software.
###end p 21
###begin title 22
Cardiomyocyte isolation and in vitro drug treatment
###end title 22
###begin p 23
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Doser1">[20]</xref>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 573 575 573 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1154 1158 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Guo1">[22]</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
Murine cardiomyocytes were isolated as described [20]. After ketamine/xylazine sedation, hearts were removed and perfused with Ca2+ -free Tyrode's solution containing (in mM): NaCl 135, KCl 4.0, MgCl2 1.0, HEPES 10, NaH2PO4 0.33, glucose 10, butanedione monoxime 10, and the solution was gassed with 5% CO2/95% O2. Hearts were digested with Liberase Blendzyme 4 (Hoffmann-La Roche Inc., Indianapolis, IN, USA) for 20 min. Left ventricles were removed and minced before being filtered. Tissue pieces were gently agitated and pellet of cells was resuspended. Extracellular Ca2+ was added incrementally back to 1.20 mM over a period of 30 min. Isolated myocytes were used within 8 hrs of isolation. Normally, a yield of 50-60% viable rod-shaped cardiomyocytes with clear sarcomere striations was achieved. Only rod-shaped myocytes with clear edges were selected for mechanical study. To directly assess the role of oxidative stress in AD-associated cardiomyocyte contractile function, a cohort of cardiomyocytes from WT and APP/PS1 mice were incubated at 37degreesC for 2 hrs in the absence or presence of the antioxidant N-acetylcysteine (NAC, 500 microM) [22] prior to mechanical function assessment.
###end p 23
###begin title 24
Cell shortening/relengthening
###end title 24
###begin p 25
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Doser1">[20]</xref>
###xml 311 312 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1242 1244 1236 1238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1252 1254 1246 1248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 1369 1371 1363 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1378 1380 1372 1374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
Mechanical properties of cardiomyocytes were assessed using a video-based edge-detection system (IonOptix Corporation, Milton, MA, USA) [20]. In brief, cells were placed in a Warner chamber mounted on the stage of an inverted microscope (Olympus, IX-70) with a buffer containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, at pH 7.4. The cells were field stimulated with suprathreshold voltage at a frequency of 0.5 Hz, 3 msec duration, using a pair of platinum wires placed on opposite sides of the chamber connected to a FHC stimulator (Brunswick, NE, USA). The polarity of stimulation electrodes was reversed frequently to avoid possible build up of electrolyte by-products. The myocyte being studied was displayed on the computer monitor using an IonOptix MydegreesC am camera, which rapidly scans the image area at every 8.3 msec such that the amplitude and velocity of shortening/relengthening is recorded with good fidelity. The soft-edge software (IonOptix) was used to capture changes in cell length during shortening and relengthening. Cell shortening and relengthening were assessed using the following indices: peak shortening (PS), which indicates peak ventricular contractility; time-to-50% and 90% PS (TPS50 and TPS90), which indicate rapid and entire phase of myocyte shortening, respectively; time-to-50% and 90% relengthening (TR50 and TR90), which indicates early and entire phase of myocyte relengthening, respectively; as well as maximal velocity of shortening/relengthening (+/- dL/dt), which depicts maximal velocity of cardiomyocyte contraction and relaxation. For duration of myocyte shortening and relengthening, 90% rather 100% of the entire duration was used in an effort to avoid noisy signal near baseline. In the case of altering stimulus frequency (from 0.1 Hz to 5.0 Hz), the steady-state contraction of myocyte was achieved (usually after the first five to six beats) before PS amplitude was recorded. The grid-crossing method was used for random cell selection to minimize the influence of heterogeneous cell contraction in response to field stimuli. Myocytes with obvious sarcolemmal blebs or spontaneous contractions were not used for mechanical recording. All measurements were performed at 25-27degreesC.
###end p 25
###begin title 26
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Intracellular Ca2+ fluorescence measurement
###end title 26
###begin p 27
###xml 218 222 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Doser1">[20]</xref>
###xml 974 976 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 995 997 983 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1233 1235 1221 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1582 1584 1568 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
A separate cohort of myocytes was loaded with fura-2/AM (0.5 microM) for 15 min and fluorescence measurements were recorded with a dual-excitation fluorescence photomultiplier system (Ionoptix) as previously described [20]. In brief, myocytes were placed on an Olympus IX-70 inverted microscope equipped with a temperature-controlled (25degreesC) Warner chamber and imaged through a Fluor x40 oil objective. Myocytes were exposed to light emitted by a 75W lamp and passed through either a 360 or a 380 nm filter (bandwidths were+/-15 nm), while being electrically stimulated to contract at 0.5 Hz. Fluorescence emissions were detected between 480-520 nm by a photomultiplier tube after first illuminating the cardiomyocytes at 360 nm for 500 msec then at 380 nm for the duration of the recording protocol (9 sec at a sampling rate of 333 Hz). The 360 nm excitation scan was repeated for another 500 msec at the end of the protocol and qualitative changes in intracellular Ca2+ concentration ([Ca2+]i) were inferred from the ratio of the fluorescence intensity at two wavelengths (360/380). This "interpolated" technique was used since 360 nm is the isobestic point for fura-2 at which the numerator is independent of intracellular Ca2+ concentration. The majority of the recording was done using the 380 nm filter (except the first and last 500 msec) since the strongest signal is the 380 nm-excited emission. The time course of the fluorescence signal decay was fit to a single exponential equation, and the time constant (tau) was used as a measure of the rate of intracellular Ca2+ decay.
###end p 27
###begin title 28
Western blot analysis
###end title 28
###begin p 29
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Doser1">[20]</xref>
###xml 1263 1264 1237 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1267 1269 1241 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 1218 1224 <span type="species:ncbi:9986">rabbit</span>
###xml 1249 1255 <span type="species:ncbi:9986">rabbit</span>
###xml 1299 1304 <span type="species:ncbi:10090">mouse</span>
###xml 1340 1346 <span type="species:ncbi:9986">rabbit</span>
###xml 1367 1371 <span type="species:ncbi:9925">goat</span>
###xml 1414 1420 <span type="species:ncbi:9986">rabbit</span>
###xml 1445 1451 <span type="species:ncbi:9986">rabbit</span>
###xml 1486 1492 <span type="species:ncbi:9986">rabbit</span>
###xml 1542 1548 <span type="species:ncbi:9986">rabbit</span>
###xml 1775 1786 <span type="species:ncbi:3704">horseradish</span>
The total protein was prepared as described [20]. In brief, tissue samples from mouse ventricles were removed and homogenized in a lysis buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 0.1% SDS, and protease inhibitor cocktail. Samples were then sonicated for 15 sec and centrifuged at 13,000x g for 20 min at 4degreesC. The protein concentration of the supernatant was determined using Protein Assay Reagent (Bio-Rad Laboratories, Richmond, CA, USA). Protein samples were then mixed 1:2 with Laemmli sample buffer with 5% 2-mercaptoethanol and heated at 95degreesC for 5 min. Equal amounts (50 microg protein/lane) of the protein mixture, or the SeeBlue Plus2 PreStained markers (Invitrogen, Carlsbad, CA, USA) were separated on 10% or 15% SDS-polyacrylamide gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad); then were transferred electrophoretically to Nitrocellulose membranes (0.2 microm pore size, Bio-Rad Laboratories, Inc, Hercules, CA, USA). Membranes were incubated for 1 hr at room temperature in a blocking solution containing 5% milk in Tris-buffered saline (TBS). After TBS washed, membranes were incubated overnight at 4degreesC with primary antibody including rabbit anti-SERCA2a (1:1,000), rabbit anti-Na+-Ca2+ exchanger (NCX, 1:1,000) and mouse anti-phospholamban (PLB, 1:2,000), rabbit anti-BiP (1:1,000), goat anti-calregulin (calreticulin) (1:1,000), rabbit anti-IRE1alpha (1:500), rabbit anti-phospho-IRE1alpha (1:1,000), rabbit anti-beta1 adrenergic receptor antibody (1:500), rabbit anti-alpha tubulin (1:1,000 as loading control) and anti-alpha smooth muscle actin (1:1,200 as loading control) antibodies. After three washes with TBS-T to remove excessive primary antibody binding, blots were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5,000) for 1 hr at room temperature. The antigens were detected by the luminescence method. Quantification of band density was determined using Quantity One software (Bio-Rad, version 4.4.0) and reported in optical density per square millimeter.
###end p 29
###begin title 30
Protein carbonyl assay
###end title 30
###begin p 31
###xml 1163 1165 1159 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1168 1170 1164 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1170 1174 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Ren2">[23]</xref>
Proteins were extracted and minced to prevent proteolytic degradation. Nucleic acids were eliminated by treating the samples with 1% streptomycin sulphate for 15 min, followed by a 10 min centrifugation (11,000xg). Protein was precipitated by adding an equal volume of 20% trichloroacetic acid (TCA) to protein (0.5 mg) and centrifuged for 1 min. The TCA solution was removed and the sample resuspended in 10 mmol/L 2, 4-dinitrophenylhydrazine (2,4-DNPH) solution. Samples were incubated at room temperature for 15-30 min. After adding 500 microL of 20% TCA, samples were centrifuged for 3 min. The supernatant was discarded, the pellet washed in ethanol: ethyl acetate and allowed to incubate at room temperature for 10 min. The samples were centrifuged again for 3 min and the ethanol: ethyl acetate steps repeated twice or more times. The precipitate was resuspended in 6 mol/L guanidine solution, centrifuged for 3 min and any insoluble debris removed. The maximum absorbance (360-390 nm) of the supernatant was read against appropriate blanks (water, 2 mol/L HCl) and the carbonyl content was calculated using the molar absorption coefficient of 22 000 mol/L-1 cm-1[23].
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
Data are presented as Mean+/-SEM. Statistical significance (p<0.05) was estimated by ANOVA or t-test, where appropriate.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
General features of animals and ECG analysis
###end title 35
###begin p 36
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Valencik1">[24]</xref>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006033-t001">Table 1</xref>
###xml 981 987 981 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g001">Fig. 1</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
Little difference was identified in tibial length, body and organ (heart, liver and kidney) weights between the APP/PS1 mice and their wild-type (WT) littermates. Both heart-to-body weight and heart weight-to-tibial length ratios were comparable between the two mouse groups. Fasting glucose levels and systolic blood pressure were similar between WT and APP/PS1 mice, excluding the potential contribution of diabetes and hypertension. Surface ECG examination showed that heart rate was significantly faster in the APP/PS1 mice compared to WT mice. Correspondingly, R-R interval was shorter in APP/PS1 mice. P-R interval, Q-T interval and QRS width were all normal in APP/PS1 mice compared with WT. Interestingly, both R wave and QRS complex amplitudes, which are reliable indicatives of myocardial contractility [24], were significantly diminished in APP/PS1 group compared with those from WT control (Table 1). Representative ECG traces from APP/PS1 and WT mice were depicted in Fig. 1.
###end p 36
###begin p 37
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
A: The Morris water maze learning curves of mean latency time for WT and APP/PS1 mice; B: Percentage of time spent in the target quadrant for WT and APP/PS1 mice during the probe trial. Data for both panels were obtained from 4 consecutive days of training (4 trials per day); C: Representative ECG traces obtained from WT and APP/PS1 mice; and D: Representative microphotographs of the H&E and Masson's trichrome stained left ventricular tissue sections from WT and APP/PS1 mice (magnification = 400x). Note that Masson's trichrome stains collagen blue to detect interstitial fibrosis. Mean+/-SEM, n = 5-6 mice for panels A and B, *p<0.05 vs. WT group.
###end p 37
###begin title 38
###xml 62 66 <span type="species:ncbi:10090">mice</span>
General characteristics and ECG properties of WT and APP/PS1) mice.
###end title 38
###begin p 39
###xml 12 13 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 20 23 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Mean+/-SEM, *p<0.05 vs. wild-type (WT) group, n = 6-11 mice per group.
###end p 39
###begin title 40
Behavioral evaluation
###end title 40
###begin p 41
###xml 102 109 102 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 119 126 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g001">Fig. 1A</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g001">Fig. 1B</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
The standard Morris water maze test was used to evaluate the spatial memory of mice from both groups. Results shown in Fig. 1A indicated that the performance of APP/PS1 mice tended to be poorer (although not significant) than that of WT mice when the platform was hidden. Following 4 days of pre-training, all mice were subjected to a probe trial with the platform taken away. Data from Fig. 1B showed that APP/PS1 mice spent significantly lesser time in the target quadrant than the WT control, indicating spatial memory impairment in the APP/PS1 mice.
###end p 41
###begin title 42
Myocardial histology
###end title 42
###begin p 43
###xml 595 602 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g001">Fig. 1D</xref>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
To assess the impact of APP/PS1 mutation on myocardial histology, histological studies were performed using the H&E and Masson's trichrome staining techniques. No overt difference was found under the light microscope with regards to the appearance of isolated cardiomyocytes from APP/PS1 and WT groups (data not shown), which was supported H&E and Masson's trichrome staining in myocardial tissue sections from WT and APP/PS1 mice. Little difference was identified for either cardiomyocyte size (H&E staining) or interstitial fibrosis (Masson's trichrome staining) between the two mouse groups (Fig. 1D).
###end p 43
###begin title 44
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Cardiomyocyte mechanics in myocytes from APP, PS1 and APP/PS1 transgenic murine model
###end title 44
###begin p 45
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Selkoe1">[1]</xref>
###xml 801 803 799 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 811 813 809 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 848 850 846 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 857 859 855 857 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 910 916 908 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g002">Fig. 2</xref>
###xml 933 935 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 940 942 938 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 946 948 944 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 955 957 953 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 1554 1556 1522 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 1563 1565 1531 1533 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 535 550 <span type="species:ncbi:10090">transgenic mice</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 1162 1167 <span type="species:ncbi:10090">mouse</span>
###xml 1683 1687 <span type="species:ncbi:10090">mice</span>
The APP/PS1 mouse model used in our study possesses concurrent mutated forms of APP and Presenilin 1 (PS1), both identified separately in human Alzheimer diseases [1]. To examine if individual mutation in APP or PS1 is capable of eliciting myocardial contractile dysfunction independently, cardiomyocyte mechanical function was assessed in the gender- and weight-matched mice with mutation of APP or PS1 (3 mice each, body weight = 27-29 g), or both (APP/PS1). The resting cell lengths (CL) were comparable in WT, APP/PS1, APP and PS1 transgenic mice. At the pacing frequency of 0.5 Hz, peak shortening amplitude (PS) and maximal velocity of shortening/relengthening (+/-dL/dt) were significantly reduced in cardiomyocytes from APP/PS1 but not APP or PS1 mouse hearts. The time-to-peak shortening (TPS50 and TPS90) and time-to-90% relengthening (TR50 and TR90) were comparable between the WT and APP/PS1 mice (Fig. 2). Similarly, TPS50, TPS90, TR50 and TR90 were unaffected by single mutation of APP or PS1 at the stimulus frequency of 0.5 Hz (data not shown). Given the higher heart rate in rodents, cell mechanical indices were also examined in WT and APP/PS1 mouse cardiomyocytes paced at 5 Hz. PS and+/-dL/dt were significantly lowered in APP/PS1 cardiomyocytes (PS: 1.67+/-0.30%; + dL/dt: 66.4+/-11.8 microm/sec; - dL/dt: -58.0+/-13.5 microm/sec, n = 18 cells) compared with those from WT group (PS: 2.88+/-0.40%; + dL/dt: 91.4+/-13.8 microm/sec; - dL/dt: -76.5+/-14.7 microm/sec, n = 21 cells, p<0.05 for all parameters between the two groups). TPS90 and TR90 were comparable between WT (72+/-3 and 83+/-4 msec, respectively) and APP/PS1 (68+/-4 and 78+/-5 msec, respectively) mice at the stimulus frequency of 5 Hz.
###end p 45
###begin title 46
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Cardiomyocyte contractile properties in WT, APP/PS1, APP and PS1 mouse hearts.
###end title 46
###begin p 47
###xml 196 198 196 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 206 208 206 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 243 245 243 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 322 325 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
A: Resting cell length (CL); B: Peak shortening (PS, normalized to CL); C: Maximal velocity of shortening (+ dL/dt); D: Maximal velocity of relengthening (- dL/dt); E: Time-to-peak shortening (TPS50 and TPS90); and F: Time-to-relengthening (TR50 and TR90). Mean+/-SEM, n = 132-135 cells from four mice per group, * p<0.05 vs. WT group.
###end p 47
###begin title 48
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Intracellular Ca2+ transient properties
###end title 48
###begin p 49
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 320 322 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 445 447 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 462 464 456 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 538 544 532 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g003">Fig. 3</xref>
###xml 600 602 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 666 671 <span type="species:ncbi:10090">mouse</span>
To further explore the possible mechanism of action underlying APP/PS1-associated cardiomyocyte mechanical dysfunction, the membrane permeable intracellular Ca2+ fluorescent dye fura-2 was used to evaluate intracellular Ca2+ homeostasis in cardiomyocytes. Our results depicted unchanged peak and resting intracellular Ca2+, as well as intracellular Ca2+ decay rate (tau) associated with a slight although significant decrease in intracellular Ca2+ rise (Delta[Ca2+]i) in cardiomyocytes from APP/PS1 mice compared with those from WT mice (Fig. 3). These data indicated the presence of intracellular Ca2+ handling defect in cardiomyocytes from this APP/PS1 transgenic mouse model of AD.
###end p 49
###begin title 50
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Intracellular Ca2+ transient properties in cardiomyocytes from WT and APP/PS1 mouse hearts.
###end title 50
###begin p 51
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 147 149 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 182 184 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 310 313 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#964;</italic>
###xml 379 382 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
A: Representative intracellular Ca2+ transients in cardiomyocytes from WT (solid line) and APP/PS1 (dotted line) mice; B: Baseline intracellular Ca2+ levels; C: Peak intracellular Ca2+ levels; D: Increase of intracellular Ca2+ in response to electrical stimuli; and E: Intracellular Ca2+ transient decay rate (tau). Mean+/-SEM, n = 62-64 cells from four mice per group, * p<0.05 vs. WT group.
###end p 51
###begin title 52
Effect of increased stimulation frequency on cardiomyocyte shortening
###end title 52
###begin p 53
###xml 201 203 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g004">Fig. 4A</xref>
###xml 756 758 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 770 775 <span type="species:ncbi:10090">mouse</span>
Mouse hearts normally contract at very high frequencies (400 beat/min), whereas our baseline mechanical assessment was conducted at 0.5 Hz. To investigate the possible role of sarcoplasmic reticulum Ca2+ storage and release in APP/PS1 mouse cardiomyocytes, a frequency-response was constructed. Cardiomyocytes were initially stimulated to contract at 0.5 Hz for 5 min to ensure steady-state before commencing the frequency sequence. While increased stimulating frequency (0.1-5.0 Hz) triggered a negative staircase in peak shortening amplitude in both WT and APP/PS1 groups. The degree of decrease was more pronounced in APP/PS1 mice at frequencies greater than 1 Hz (Fig. 4A), indicating existence of compromised SR storage and release of intracellular Ca2+ in APP/PS1 mouse hearts.
###end p 53
###begin title 54
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
A: Peak shortening amplitude of cardiomyocytes isolated from WT and APP/PS1 mouse hearts at different stimulus frequencies (0.1-5.0 Hz).
###end title 54
###begin p 55
###xml 386 389 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
Peak shortening amplitude is normalized to value obtained at 0.1 Hz of the same cell. B: Adrenergic response in cardiomyocytes from WT and APP/PS1 mice. Data are shown as percent change from baseline in the absence of adrenergic agonists, norepinephrine (NE, 1 microM) or isoproterenol (ISO, 0.1 and 1 microM). Mean+/-SEM, n = 13-26 cells from four to six mice per data point, * p<0.05 vs. WT group.
###end p 55
###begin title 56
Effect of norepinephrine and isoproterenol on cardiomyocyte shortening
###end title 56
###begin p 57
###xml 236 243 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 249 256 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g004">Fig. 4B</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
To explore the alterations in cardiac excitation-contraction coupling, cardiomyocytes from APP/PS1 and WT mice were exposed to norepinephrine (NE, 1 microM) and isoproterenol (ISO, 0.1 and 1 microM) and myocyte shortening was examined. Results from Fig. 4B displayed a reduced responsiveness to both NE and ISO in cardiomyocytes from APP/PS1 mice compared with those from WT group.
###end p 57
###begin title 58
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Protein expression of intracellular Ca2+ regulatory proteins, ER stress markers and beta-adrenergic receptor
###end title 58
###begin p 59
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Bers1">[18]</xref>
###xml 278 284 278 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g005">Fig. 5</xref>
###xml 643 650 639 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 660 666 656 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g006">Fig. 6</xref>
###xml 973 974 958 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1044 1050 1029 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g007">Fig. 7</xref>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
Given that intracellular Ca2+ homeostasis is tightly regulated by a cascade of intracellular Ca2+ regulatory proteins including SERCA, phospholamban (PLB) and NCX [18], Western blot analysis was performed to evaluate the expression of SERCA2a, PLB and NCX. Our results shown in Fig. 5 revealed a significantly reduced expression of PLB associated with unchanged SERCA2a and NCX in myocardium from APP/PS1 mice compared with the WT group. To explore if alteration in protein trafficking and folding was involved in myocardial dysfunction in APP/PS1 mice, protein expression of the ER stress markers IRE-1alpha, calregulin and Bip was examined. Results shown in Fig. 6 revealed that IRE-1alpha, IRE-1alpha phosphorylation, calregulin and Bip were all comparable between the APP/PS1 and WT groups, not favoring a potential involvement of protein misfolding in APP/PS1 mutation-associated cardiac dysfunction. Our further immunoblotting analysis revealed similar levels of beta1-adrenergic receptor in myocardium between the APP/PS1 and WT groups (Fig. 7).
###end p 59
###begin title 60
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Expression of intracellular Ca2+ regulatory proteins in myocardium from WT and APP/PS1 mice.
###end title 60
###begin p 61
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 214 216 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 262 265 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
A: Representative gel blots depicting the expression of SERCA2a, NCX and PLB using specific antibodies. alpha-tubulin was used as an internal loading control; B: SERCA2a; Panel C: Phospholamban (PLB); and D: Na+-Ca2+ exchanger (NCX). Mean+/-SEM, n = 4, * p<0.05 vs. WT group.
###end p 61
###begin title 62
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Expression of ER stress markers in myocardium from WT and APP/PS1 mice.
###end title 62
###begin p 63
A: Representative gel blots depicting the ER stress markers IRE1alpha, phosphorylated IRE1alpha, BiP and calregulin (calreticulin) using specific antibodies. alpha-tubulin was used as an loading control; B: phosphorylated IRE 1alpha/IRE 1alpha ratio; C: calregulin; and D: Bip. Mean+/-SEM, n = 4.
###end p 63
###begin title 64
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Expression of beta1-adrenergic receptor (beta1-AR) in myocardium from WT and APP/PS1 mice.
###end title 64
###begin p 65
Inset: Representative gel blots of beta1-AR and alpha-smooth muscle actin (used as an internal loading control). Mean+/-SEM, n = 4.
###end p 65
###begin title 66
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Protein carbonyl formation and effect of antioxidant on cardiomyocyte mechanics in APP/PS1 mice
###end title 66
###begin p 67
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Smith1">[25]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Picklo1">[28]</xref>
###xml 253 260 253 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 897 903 887 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006033-g008">Fig. 8</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
Oxidative stress and subsequent protein oxidation have been reported to play an important role in the pathogenesis of AD brain [25]-[28]. To assess the cardiac oxidative protein damage in the APP/PS1 AD model, protein carbonyl formation was determined. Results from the present study revealed that myocardial protein carbonyl formation was significantly higher in APP/PS1 (3.139+/-0.716 nmol/mg protein) than WT mice (0.993+/-0.215 nmol/mg protein, p<0.05 between the two groups). To further examine the role of oxidative stress in APP/PS1-induced cardiac contractile defects, freshly isolated cardiomyocytes from WT and APP/PS1 mice were incubated for 2 hrs in the absence or presence of the antioxidant NAC (500 microM). Our data revealed that NAC effectively ablated APP/PS1-induced mechanical defects (depressed PS and+/-dL/dt) without eliciting any effects on cardiomyocyte mechanics itself (Fig. 8). These data provided direct evidence for a likely role of oxidative stress in AD-induced cardiac contractile dysfunction, consistent with elevated protein carbonyl formation.
###end p 67
###begin title 68
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Cardiomyocyte contractile properties in myocytes from WT and APP/PS1 mice incubated for 2 hrs in the presence or absence of the antioxidant N-acetylcysteine (NAC, 500 microM).
###end title 68
###begin p 69
###xml 235 237 235 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 297 300 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 320 323 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
A: Resting cell length; B: Peak shortening (normalized to cell length); C: Maximal velocity of shortening (+ dL/dt); D: Maximal velocity of relengthening (- dL/dt); E: Time-to-peak shortening (TPS); and F: Time-to-90% relengthening (TR90). Mean+/-SEM, n = 50 cells from 3 mice per group, * p<0.05 vs. WT group, # p<0.05 vs.APP/PS1 group.
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 815 819 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Jankowsky2">[29]</xref>
###xml 821 825 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Savonenko1">[30]</xref>
###xml 943 945 937 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
Data from our current study have clearly depicted cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 (APP/PS1) transgenic model of AD. The major mechanical defects observed in cardiomyocytes from APP/PS1 mice include decreased cell shortening, reduced velocities of shortening/relengthening at the stimulus of both 0.5 Hz and 5 Hz and exaggerated frequency response. Our results indicated that individual mutation in either APP or PS1 alone is insufficient to trigger overtly compromised cardiomyocyte contractile function compared with concurrent presence of both. These findings are consistent with literature that the expression of APPswe alone results in less Abeta production than APPswe/PS1dE9 and PS1dE9 transgene enhances the production of Abeta in APPswe mice while little effect exerted by itself [29], [30]. Our further study revealed the possible contribution of decreased adrenergic response, dysregulated intracellular Ca2+ homeostasis, protein damage and oxidative stress to impaired cardiomyocyte mechanical function in APP/PS1 mice.
###end p 71
###begin p 72
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Nelson1">[31]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Heron1">[32]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-delaTorre1">[33]</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
In our study, the APP/PS1 mice were euglycemic and normotensive, excluding potential contribution of diabetes and hypertension to the compromised cardiac function. Our data revealed overt mechanical changes associated with exacerbated spatial learning and memory impairment in APP/PS1 mice. Approximately 2% of populations in developed countries are afflicted with AD [31]. In 2004, AD was ranked the 7th among the 10 leading causes of death in the US [32]. Although there has been an intensive effort to understand AD, the main focus thus far is to elucidate the pathogenesis of neurodegeneration in AD brain with rather limited data for the organ-specific complications of AD. During the past two decades, a growing body of evidence has revealed many risk factors of cardiac diseases which are also detrimental to AD, indicating a close link between cardiac diseases and AD [33]. To the best of our knowledge, our current study is the first report to provide direct evidence of cardiac dysfunction in AD using this transgenic line.
###end p 72
###begin p 73
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Giubilei1">[34]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Raskind1">[35]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Wang1">[36]</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
In our study, the heart rate was higher in AD mice. This may be associated with cardiac autonomic dysfunction in AD although conflicting data were seen. Elevated catecholamine levels and ablated vagal tone were reported in AD patients [34], [35], supporting the higher heart rate observed in our current study. Impaired vagal parasympathetic function was reported in AD patients evaluated by R-R interval variation (RRIV) and sympathetic skin response and orthostatic cardiovascular reflexes [36]. In addition, QT dispersion was found to be tightly correlated with the degree of cognitive impairment in AD patients. As shown in our current study, surface ECG revealed for the first time increased heart rate, reduced RR interval and diminished QRS amplitude in the APP/PS1 mice compared with WT mice.
###end p 73
###begin p 74
###xml 482 484 480 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 509 511 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 543 545 541 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 579 581 577 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 634 636 632 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 701 703 699 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 778 780 776 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 815 817 813 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 824 826 822 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 966 968 964 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1252 1254 1250 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1730 1732 1728 1730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1745 1753 1743 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en route</italic>
###xml 1799 1803 1797 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Bers1">[18]</xref>
###xml 2079 2087 2077 2085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
###xml 1283 1289 <span type="species:ncbi:10090">murine</span>
###xml 1521 1526 <span type="species:ncbi:10090">mouse</span>
###xml 1915 1919 <span type="species:ncbi:10090">mice</span>
###xml 2027 2031 <span type="species:ncbi:10090">mice</span>
###xml 2179 2183 <span type="species:ncbi:10090">mice</span>
The most prominent cardiac dysfunctions in the APP/PS1 AD mouse model observed in our study were reduced cardiomyocyte contraction and diminished maximal velocity of contraction/relaxation (+/-dL/dt) at both low and high stimulus frequencies associated with unchanged duration of contraction and relaxation. Several factors may contribute to the impaired mechanical function including defected contractile proteins (e.g., actin, myosin heavy chain isoform), reduced intracellular Ca2+ release, depressed SR Ca2+ load and altered myofilament Ca2+ sensitivity. The intracellular Ca2+ measurement confirmed a decrease in intracellular Ca2+ rise associated with unchanged resting and peak intracellular Ca2+ levels in cardiomyocytes from APP/PS1 mice. The unchanged intracellular Ca2+ decay coincides with the normal TR50 and TR90 in APP/PS1 mouse cardiomyocytes, which is also supported by the normal protein levels of SERCA2a and NCX, the main machineries to remove Ca2+ from cytosolic space for cardiac relaxation to occur, in APP/PS1 myocardium. In addition, our data revealed exaggerated decline in the steady-state myocyte peak shortening in response to increased stimulating frequency in APP/PS1 mice, suggesting a possibly reduced capacity in SR Ca2+ storage and release in this murine model of AD. The reduced cardiomyocyte shortening capacity received convincing support from the reduced R-wave height in ECG reading. Our data revealed down-regulation of phospholamban, an endogenous inhibitor of SERCA, in APP/PS1 mouse hearts. Although the link between reduced phospholamban expression and altered cardiac contractile function in APP/PS1 hearts is unclear, reduced phospholamban levels may trigger altered intracellular Ca2+ homeostasis en route to affect cardiomyocyte contractile function [18]. Our study revealed enhanced protein carbonyl formation in the absence of ER stress in myocardium from APP/PS1 mice, suggesting a likely role of oxidative stress in the altered cardiomyocyte contractile function in APP/PS1 mice. This notion received further support from our in vitro study where antioxidant NAC alleviates the cardiomyocyte mechanical dysfunction in APP/PS1 mice.
###end p 74
###begin p 75
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Brodde1">[37]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Brodde1">[37]</xref>
###xml 442 443 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 698 702 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Brodde1">[37]</xref>
###xml 1037 1041 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Estorch1">[38]</xref>
###xml 1042 1046 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-WadaIsoe1">[40]</xref>
###xml 1162 1166 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006033-Wieland1">[41]</xref>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 807 815 <span type="species:ncbi:9606">patients</span>
###xml 935 943 <span type="species:ncbi:9606">patients</span>
###xml 1268 1276 <span type="species:ncbi:9606">patients</span>
###xml 1322 1330 <span type="species:ncbi:9606">patients</span>
Catecholamine desensitization is a hallmark of heart failure [37]. It has been shown that heart failure may trigger catecholamine desensitization to both isoproterenol and norepinephrine in the presence and absence of ganglionic blockade [37]. This is in line with our observation of reduced responsiveness to norepinephrine and isoproterenol in APP/PS1 mouse cardiomyocytes. However, the lack of overt change in myocardial histology and beta1-adrenergic receptor expression suggest the absence of any advanced heart failure and adrenergic desensitization in APP/PS1 hearts. Although sympathetic denervation may lead to postsynaptic supersensitivity due to lack of neural uptake for norepinephrine [37], to what extent adrenergic denervation or desensitization contributes to myocardial complications in AD patients remains controversial. Several reports have been seen to discriminate changes in cardiac sympathetic innervation of AD patients from other neurodegenerative disease such as dementia with Lewy bodies and vascular dementia [38]-[40]. These studies measured cardiac uptake of metaiodobenzylguanidine (MIBG), a physiologic analogue of norepinephrine [41], as a mean of noninvasive index of the integrity of sympathetic neurotransmission in the heart of AD patients. It was found that cardiac MIBG uptake in AD patients was essentially unaffected compared with other neourodegenrative diseases. Nevertheless, subtle differences may exist in the diagnostic criteria of AD and different stages of disease process.
###end p 75
###begin p 76
###xml 246 248 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 328 330 328 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 540 542 540 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
In summary, this study provides evidence for the first time of altered cardiomyocyte contractile function in the APP/PS1 transgenic model of AD. Cardiomyocytes from APP/PS1 mice exhibited decreased inotropic response and impaired intracellular Ca2+ homeostasis possibly due to mechanisms associated with reduced intracellular Ca2+ release, altered expression in Ca2+ regulatory proteins, reduced adrenergic function and oxidative damage. However, other mechanisms should not be excluded at this time such as susceptibility of myofilament Ca2+ sensitivity and altered expression of cardiac contractile proteins. Future study is warranted to elucidate the subcellular signaling mechanisms responsible for cardiac abnormalities in AD.
###end p 76
###begin p 77
The authors would like to thank Drs. Susan Zhang and Ji Li from University of Wyoming School of Pharmacy for technical assistance.
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
Alzheimer's disease: genes, proteins, and therapy.
###end article-title 79
###begin article-title 80
Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.
###end article-title 80
###begin article-title 81
Stroke and the risk of Alzheimer disease.
###end article-title 81
###begin article-title 82
###xml 39 46 <span type="species:ncbi:9606">persons</span>
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
###end article-title 82
###begin article-title 83
Aggregation of vascular risk factors and risk of incident Alzheimer disease.
###end article-title 83
###begin article-title 84
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.
###end article-title 84
###begin article-title 85
Diabetes mellitus and dementia.
###end article-title 85
###begin article-title 86
Hypertension and the risk of mild cognitive impairment.
###end article-title 86
###begin article-title 87
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.
###end article-title 87
###begin article-title 88
Cardiovascular risk factors for Alzheimer's disease.
###end article-title 88
###begin article-title 89
Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity.
###end article-title 89
###begin article-title 90
Presenilin 1 is essential for cardiac morphogenesis.
###end article-title 90
###begin article-title 91
Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling.
###end article-title 91
###begin article-title 92
Mutations of presenilin genes in dilated cardiomyopathy and heart failure.
###end article-title 92
###begin article-title 93
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.
###end article-title 93
###begin article-title 94
###xml 73 88 <span type="species:ncbi:10090">transgenic mice</span>
Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice.
###end article-title 94
###begin article-title 95
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
###end article-title 95
###begin article-title 96
Cardiac excitation-contraction coupling.
###end article-title 96
###begin article-title 97
###xml 37 43 <span type="species:ncbi:10090">murine</span>
Endoplasmic reticulum stress impairs murine cardiomyocyte contractile function via an Akt-dependent mechanism.
###end article-title 97
###begin article-title 98
Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction.
###end article-title 98
###begin article-title 99
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.
###end article-title 99
###begin article-title 100
Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction 1.
###end article-title 100
###begin article-title 101
###xml 110 114 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Increases in insulin-like growth factor-1 level and peroxidative damage after gestational ethanol exposure in rats.
###end article-title 101
###begin article-title 102
Integrin activation in the heart: a link between electrical and contractile dysfunction?
###end article-title 102
###begin article-title 103
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
###end article-title 103
###begin article-title 104
###xml 129 133 <span type="species:ncbi:10090">mice</span>
Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.
###end article-title 104
###begin article-title 105
Protein oxidation in the brain in Alzheimer's disease.
###end article-title 105
###begin article-title 106
Carbonyl toxicology and Alzheimer's disease.
###end article-title 106
###begin article-title 107
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
###end article-title 107
###begin article-title 108
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
###end article-title 108
###begin article-title 109
Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.
###end article-title 109
###begin article-title 110
Deaths: leading causes for 2004.
###end article-title 110
###begin article-title 111
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.
###end article-title 111
###begin article-title 112
###xml 33 41 <span type="species:ncbi:9606">patients</span>
Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms.
###end article-title 112
###begin article-title 113
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.
###end article-title 113
###begin article-title 114
Cardiovascular autonomic functions in Alzheimer's disease.
###end article-title 114
###begin article-title 115
Cardiac adrenoceptors: physiological and pathophysiological relevance.
###end article-title 115
###begin article-title 116
[Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging].
###end article-title 116
###begin article-title 117
Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).
###end article-title 117
###begin article-title 118
Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
###end article-title 118
###begin article-title 119
Myocardial imaging with a radioiodinated norepinephrine storage analog.
###end article-title 119
###begin p 120
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 120
###begin p 121
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by the University of Wyoming Northern Rockies Regional INBRE (5P20RR016474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 121

